The Global Cell Lysis and Disruption Market Size accounted for USD 4.6 Billion in 2021 and is projected to achieve a market size of USD 10.1 Billion by 2030 rising at a CAGR of 9.2% from 2022 to 2030. The rising application in novel gene expression protocols is the leading aspect that is fueling the cell lysis and disruption market share. Additionally, increasing government funding for research is a popular cell lysis and disruption market trend that is fueling the industry demand from 2022 to 2030.
Cell Lysis and Disruption Market Report Statistics
- Global cell lysis and disruption market revenue is estimated to reach USD 10.1 Billion by 2030 with a CAGR of 9.2% from 2022 to 2030
- North America cell lysis and disruption market share accounted for over 42% shares in 2021
- Based on technique, reagent-based accounted for over 65% of the overall market share in 2021
- On the basis of cell type, mammalian cells generated revenue over USD 2 billion in 2021
- Asia-Pacific cell lysis and disruption market growth will achieve fastest CAGR from 2022 to 2030
- Growing innovation in biopharma and pharma companies fuels the global cell lysis and disruption market value
Cell lysis is one of the important steps in biological studies for removing biological substances and using them to achieve their corresponding study objectives in multiple downstream applications. In many sectors, from pharmaceuticals to food, cosmetics, and biotechnology, cell lysis is used. It is performed to break cells open to bypass shear forces that can denature or degrade cell proteins and DNA. Several methods of effective cell disorders are used to accomplish mechanical homogenization, ultrasound, or chemical disorder with various cell lysis reagents.
Global Cell Lysis and Disruption Market Dynamics
Market Drivers
- Expansion of biopharmaceutical and biotechnology industries
- Growth in government funding for research and development
- Rising application in novel gene expression protocols
- Increasing prevalence of chronic diseases
Market Restraints
- High cost associated with instrument set-up
- Shortage of skilled personnel
Market Opportunities
- Advancements in instruments, homogenizers, and chemical lysis methods
- Growing emphasis on personalized medicine
Cell Lysis and Disruption Market Report Coverage
| Market |
Cell Lysis and Disruption Market |
| Cell Lysis and Disruption Market Size 2021 |
USD 4.6 Billion |
| Cell Lysis and Disruption Market Forecast 2030 |
USD 10.1 Billion |
| Cell Lysis and Disruption Market CAGR During 2022 - 2030 |
9.2% |
| Cell Lysis and Disruption Market Analysis Period |
2018 - 2030 |
| Cell Lysis and Disruption Market Base Year |
2021 |
| Cell Lysis and Disruption Market Forecast Data |
2022 - 2030 |
| Segments Covered |
By Technique, By Product, By Cell Type, By Application, By End-Use, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Thermo Fisher Scientific, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Qiagen NV, Merck KGaA, Becton Dickinson & Company (BD), Microfluidics International Corporation, Claremont BioSolutions, LLC, BioVision, Inc., Parr Instrument Company, Covaris, Inc., and Qsonica LLC. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Cell Lysis and Disruption Market Dynamics
Engineering advances in cellular organel release processes have paved the way for the increased implementation of cell disruption techniques. Because biopharmaceuticals are collected and purified by cells, increased demand would result in subsequent market growth. Moreover, progress is anticipated to boost progressively in this area in the field of proteomics, metabolomics, and personalized medicine. However, the high price of equipment combined with the lack of qualified experts will in some way limit the generation of income. Increased investments in R&D linked to biotechnology, both by different governments and private organizations, and the market should be considerably further driven by scholars. Furthermore, the increase in the incidence of different illnesses and demand for new treatments is anticipated to stimulate market growth.
Expansion into the biopharmaceutical sector will provide fresh market growth opportunities because cell lysis and disturbance are part of the recovery and purification of biopharmaceuticals. In the course of the bioprocess, it will also be expected that the adoption of biotech processes in the pharmaceutical, agricultural and bio-service sectors will drive the market progress. The increase in demand for effective tumor dissociation machinery has resulted in the growth of new microfluidics products. Ineffective dissociation of tumor tissue in single cells, microfluidic devices are helpful and thereby improve cellular recoach in terms of amount and purity.
High maintenance and costly devices, which could hamper the market growth in developing areas, are connected with cell-based studies. Cell-based research should be correctly sustained because, in any event, contamination could hinder the general test or study. High maintenance and heavy costs of equipment, such as ultrasound and homogenization, could therefore be used as restrictive variables for the development of the industry in cell lysis. Problems in the mechanical method to apply at the microscale stage and regulatory compliance are other factors restricting this market's development.
Cell Lysis and Disruption Market Segmentation
The worldwide cell lysis and disruption market is split based on technique, product, cell type, application, end-use, and geography.
Cell Lysis and Disruption Market By Technique
- Reagent-Based
- Physical Disruption
- Mechanical Homogenization
- Temperature Treatments
- Pressure Homogenization
- Ultrasonic Homogenization
According to the cell lysis and disruption industry analysis, the reagent-based sub-segment dominated with 45% of the share in 2021 and is expected to continue its dominance in the coming years from 2022 to 2030. In this market, the main players for extraction of intracellular content traditionally embraced physical disturbance techniques. However, these techniques have now been adopted comparatively less because of the costly and cumbersome equipment necessity. Due to the presence of variability in the device, it is difficult to repeat physical disruptive methods, thereby reducing its penetration into the market. Reagent-based methods, by contrast, don't ruin final products' biological activities, are gentle, and are ideal for laboratory samples.
Cell Lysis and Disruption Market By Product
- Instruments
- Sonicator
- High Pressure Homogenizers
- Microfluidizer
- French Press
- Bead Mill
- Other Instruments
- Reagents & Consumables
- Enzymes
- Ionic Detergent
- Detergent Solutions
- Zwitterionic Detergent
- Nonionic Detergent
- Kits & Reagents
As per the cell lysis and disruption market forecast, the reagents and consumables represented the biggest proportion of revenues. In addition, the enzymes witnessed a strong growth in the cell lysis & disruption industry and are expected to develop more quickly in the coming years. Application for the selective discharge of product and regulated lysis, which are biological specific to the method, are factors that attribute the estimated share. Because of the specificity of the enzyme, bacterial, plant, yeast and mammalian samples have different kits and enzymes. These enzymes can be sold in a number of shapes.
Cell Lysis and Disruption Market By Cell Type
- Yeast/Algae/Fungi
- Bacterial Cells
- Mammalian Cells
- Plant Cells
The most important part in 2021 was the mammalian cell segment which is anticipated to stay dominant in the prediction era. Mammalian cultivation systems are widely used when virals, therapeutic proteins, and other recombinant products are bio-produced. Further, 3D mammalian culture systems are expected to be used for stem cell research and cancer research to increase the development of the sector. Because the efficiency of reagents varies according to the type of cell, major companies have specifically produced reagents for mammalian cells. Merck Millipore offers, for example, a variety of mammalian lysis reagents used for mammalian phosphorylated, cytosolic, and nuclear protein preparations. Some products are the extraction of CytoBuster protein reagent, the extraction kit for NucBuster protein, the phosphoSafe, and the kits for ProteoExtract.
Cell Lysis and Disruption Market By Application
- Downstream Processing
- Protein Isolation
- Nucleic Acid Isolation
- Cell Organelle Isolation
These techniques are widely used to isolate protein and process biopharmaceuticals downstream. Protein isolation includes proteomics, western blotting, and immunoprecipitation as key fields of implementation. The demand is anticipated to fuel the development of the segment for effective and quick lysis methods, which may extract proteins with minimal disintegration or oxidation. Another challenge that has to be resolved by pronouncing studies in this section is the viscosity that results from cell debris and genomic contamination. Advanced bioprocessing reagents and machinery are expected to be developed to facilitate market growth and complement established disturbance processes.
Cell Lysis and Disruption Market By End-Use
- Hospitals & Diagnostic Labs
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Cell Banks
The most important market share of academic and research institutions were in 2021. This is because there is a wide range of biotechnology institutes that examine molecular biology and methods for bioprocesses, using protocols for cell lysis. The protocols for the testing and study of the tumorigenicity resulted in significant demand in banking biospecimen for cell disruption techniques. Clinical drug development study is anticipated to drive growth in the coming years.
Cell Lysis and Disruption Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
The Middle East & Africa (MEA)
- Gulf Cooperation Council (GCC)
- South Africa
- Rest of the Middle East & Africa
Cell Lysis and Disruption Market Regional Analysis
Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The biggest share of income in 2021 was represented in North America. Different public initiatives in the U.S. and Canada that promote research into molecular biology, precision medicine, and cancer will boost cell lysis and the development of the market for disturbance in this region. Both high private and public spending on target therapies and novel discoveries of drugs are expected to boost demand for the therapy of multiple complex and rare diseases. However, Asia Pacific will be the fastest-increasing country in the forecast period, given that important firms in emerging markets are increasingly interested in making greater earnings.
Cell Lysis and Disruption Market Players
Some of the cell lysis and disruption companies are Thermo Fisher Scientific, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Qiagen NV, Merck KGaA, Becton Dickinson & Company (BD), Microfluidics International Corporation, Claremont BioSolutions, LLC, BioVision, Inc., Parr Instrument Company, Covaris, Inc., and Qsonica LLC. Competitive market dynamics arise through strategic initiatives, which include fusion and acquisitions, partnerships, and joint ventures. These businesses concentrated on new acquisitions/collaborations for product growth in order to strengthen their market position.
These companies offer a broad variety of products and have a large worldwide distribution system. Small players, particularly in Asian emerging markets, also enter the market. However, the market penetration of fresh entrants will be reduced by a strict legislative structure and high-quality standards set by market leaders.
CHAPTER 1. Industry Overview of Cell Lysis and Disruption Market
1.1. Definition and Scope
1.1.1. Definition of Cell Lysis and Disruption
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cell Lysis and Disruption Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cell Lysis and Disruption Market By Technique
1.2.3. Cell Lysis and Disruption Market By Product
1.2.4. Cell Lysis and Disruption Market By Cell Type
1.2.5. Cell Lysis and Disruption Market By Application
1.2.6. Cell Lysis and Disruption Market By End-Use
1.2.7. Cell Lysis and Disruption Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Cell Lysis and Disruption Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Cell Lysis and Disruption Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Cell Lysis and Disruption Market By Technique
4.1. Introduction
4.2. Cell Lysis and Disruption Revenue By Technique
4.2.1. Cell Lysis and Disruption Revenue (USD Billion) and Forecast, By Technique, 2018-2030
4.2.2. Reagent-Based
4.2.2.1. Reagent-Based Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.2. Detergent
4.2.2.2.1. Detergent Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.3. Enzymatic
4.2.2.3.1. Enzymatic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Physical Disruption
4.2.3.1. Physical Disruption Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.2. Mechanical Homogenization
4.2.3.2.1. Mechanical Homogenization Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.3. Temperature Treatments
4.2.3.3.1. Temperature Treatments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.4. Pressure Homogenization
4.2.3.4.1. Pressure Homogenization Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.5. Ultrasonic Homogenization
4.2.3.5.1. Ultrasonic Homogenization Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Cell Lysis and Disruption Market By Application
5.1. Introduction
5.2. Cell Lysis and Disruption Revenue By Application
5.2.1. Cell Lysis and Disruption Revenue (USD Billion) and Forecast, By Application, 2018-2030
5.2.2. Instruments
5.2.2.1. Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.2. Sonicator
5.2.2.2.1. Sonicator Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.3. High Pressure Homogenizers
5.2.2.3.1. High Pressure Homogenizers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.4. Microfluidizer
5.2.2.4.1. Microfluidizer Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.5. French Press
5.2.2.5.1. French Press Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.6. Bead Mill
5.2.2.6.1. Bead Mill Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.7. Other Instruments
5.2.2.7.1. Other Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Reagents & Consumables
5.2.3.1. Reagents & Consumables Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Enzymes
5.2.4.1. Enzymes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4.2. Ionic Detergent
5.2.4.2.1. Ionic Detergent Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4.3. Detergent Solutions
5.2.4.3.1. Detergent Solutions Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4.4. Zwitterionic Detergent
5.2.4.4.1. Zwitterionic Detergent Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4.5. Nonionic Detergent
5.2.4.5.1. Nonionic Detergent Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Kits & Reagents
5.2.5.1. Kits & Reagents Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Cell Lysis and Disruption Market By Cell Type
6.1. Introduction
6.2. Cell Lysis and Disruption Revenue By Cell Type
6.2.1. Cell Lysis and Disruption Revenue (USD Billion) and Forecast, By Cell Type, 2018-2030
6.2.2. Yeast/Algae/Fungi
6.2.2.1. Yeast/Algae/Fungi Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Bacterial Cells
6.2.3.1. Bacterial Cells Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Mammalian Cells
6.2.4.1. Mammalian Cells Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Plant Cells
6.2.5.1. Plant Cells Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Cell Lysis and Disruption Market By Application
7.1. Introduction
7.2. Cell Lysis and Disruption Revenue By Application
7.2.1. Cell Lysis and Disruption Revenue (USD Billion) and Forecast, By Application, 2018-2030
7.2.2. Downstream Processing
7.2.2.1. Downstream Processing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Protein Isolation
7.2.3.1. Protein Isolation Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Nucleic Acid Isolation
7.2.4.1. Nucleic Acid Isolation Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.5. Cell Organelle Isolation
7.2.5.1. Cell Organelle Isolation Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. Cell Lysis and Disruption Market By End-Use
8.1. Introduction
8.2. Cell Lysis and Disruption Revenue By End-Use
8.2.1. Cell Lysis and Disruption Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
8.2.2. Hospitals & Diagnostic Labs
8.2.2.1. Hospitals & Diagnostic Labs Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.3. Academic & Research Institutes
8.2.3.1. Academic & Research Institutes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.4. Pharmaceutical & Biotechnology Companies
8.2.4.1. Pharmaceutical & Biotechnology Companies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.5. Others
8.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 9. North America Cell Lysis and Disruption Market By Country
9.1. North America Cell Lysis and Disruption Market Overview
9.2. U.S.
9.2.1. U.S. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
9.2.2. U.S. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
9.2.3. U.S. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
9.2.4. U.S. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
9.2.5. U.S. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Canada
9.3.1. Canada Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
9.3.2. Canada Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3.3. Canada Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
9.3.4. Canada Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
9.3.5. Canada Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. North America PEST Analysis
CHAPTER 10. Europe Cell Lysis and Disruption Market By Country
10.1. Europe Cell Lysis and Disruption Market Overview
10.2. U.K.
10.2.1. U.K. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
10.2.2. U.K. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
10.2.3. U.K. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
10.2.4. U.K. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
10.2.5. U.K. Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Germany
10.3.1. Germany Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
10.3.2. Germany Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3.3. Germany Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
10.3.4. Germany Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
10.3.5. Germany Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. France
10.4.1. France Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
10.4.2. France Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4.3. France Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
10.4.4. France Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
10.4.5. France Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Spain
10.5.1. Spain Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
10.5.2. Spain Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
10.5.3. Spain Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
10.5.4. Spain Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
10.5.5. Spain Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.6. Rest of Europe
10.6.1. Rest of Europe Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
10.6.2. Rest of Europe Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
10.6.3. Rest of Europe Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
10.6.4. Rest of Europe Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
10.6.5. Rest of Europe Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Cell Lysis and Disruption Market By Country
11.1. Asia Pacific Cell Lysis and Disruption Market Overview
11.2. China
11.2.1. China Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
11.2.2. China Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
11.2.3. China Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
11.2.4. China Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
11.2.5. China Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. Japan
11.3.1. Japan Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
11.3.2. Japan Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
11.3.3. Japan Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
11.3.4. Japan Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
11.3.5. Japan Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. India
11.4.1. India Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
11.4.2. India Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
11.4.3. India Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
11.4.4. India Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
11.4.5. India Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Australia
11.5.1. Australia Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
11.5.2. Australia Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
11.5.3. Australia Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
11.5.4. Australia Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
11.5.5. Australia Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.6. South Korea
11.6.1. South Korea Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
11.6.2. South Korea Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
11.6.3. South Korea Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
11.6.4. South Korea Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
11.6.5. South Korea Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
11.7.2. Rest of Asia-Pacific Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
11.7.3. Rest of Asia-Pacific Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
11.7.4. Rest of Asia-Pacific Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
11.7.5. Rest of Asia-Pacific Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Cell Lysis and Disruption Market By Country
12.1. Latin America Cell Lysis and Disruption Market Overview
12.2. Brazil
12.2.1. Brazil Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
12.2.2. Brazil Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
12.2.3. Brazil Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
12.2.4. Brazil Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
12.2.5. Brazil Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.3. Mexico
12.3.1. Mexico Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
12.3.2. Mexico Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
12.3.3. Mexico Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
12.3.4. Mexico Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
12.3.5. Mexico Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.4. Rest of Latin America
12.4.1. Rest of Latin America Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
12.4.2. Rest of Latin America Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
12.4.3. Rest of Latin America Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
12.4.4. Rest of Latin America Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
12.4.5. Rest of Latin America Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Cell Lysis and Disruption Market By Country
13.1. Middle East & Africa Cell Lysis and Disruption Market Overview
13.2. GCC
13.2.1. GCC Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
13.2.2. GCC Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
13.2.3. GCC Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
13.2.4. GCC Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
13.2.5. GCC Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.3. South Africa
13.3.1. South Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
13.3.2. South Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
13.3.3. South Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
13.3.4. South Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
13.3.5. South Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Technique, 2018-2030
13.4.2. Rest of Middle East & Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Product, 2018-2030
13.4.3. Rest of Middle East & Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Cell Type, 2018-2030
13.4.4. Rest of Middle East & Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By Application, 2018-2030
13.4.5. Rest of Middle East & Africa Cell Lysis and Disruption Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Cell Lysis and Disruption Market
14.1. Cell Lysis and Disruption Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Cell Lysis and Disruption Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Thermo Fisher Scientific, Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Million), 2021
15.1.3.2. Thermo Fisher Scientific, Inc. AG 2021 Cell Lysis and Disruption Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Danaher Corporation
15.3. F. Hoffmann-La Roche Ltd
15.4. Bio-Rad Laboratories, Inc.
15.5. Miltenyi Biotec GmbH
15.6. Qiagen NV
15.7. Merck KGaA
15.8. Becton Dickinson & Company (BD)
15.9. Microfluidics International Corporation
15.10. Claremont BioSolutions, LLC
15.11. BioVision, Inc.
15.12. Parr Instrument Company
15.13. Covaris, Inc.
15.14. Qsonica LLC
